Cite

HARVARD Citation

    Bota, D. et al. (2021). Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data. Neuro-oncology advances. 3 (1), p. . [Online]. 
  
Back to record